Have you've ever wanted to know how a medical device gets created? Or wondered how an innovative idea eventually makes it to the market in the medical field? Today, we are very fortunate to have Dr. Ted Lamson joining us on the podcast. He is a medical device inventor, and he is responsible for a system that is now providing thousands of men with relief from their prostate symptoms. Be sure to listen in today, to find out about this device, and how it came to fruition. Dr. Lamson is co-founder of Neo Tract, and he is a primary inventor of the UroLift System. He served as President and CEO for the first five years of the company. He has more than twenty-five years of experience in the medical device industry in the fields of urology, interventional cardiology, ENT, radiology, and cardiothoracic surgery and he holds over eighty patents. Dr. Lamson holds a Ph.D. and Master of Science in Bioengineering from Pennsylvania State University. Stay tuned for more! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Lamson talks about what sparked his interest in BPH (enlargement of the prostate). The next step in trying to come up with a solution for BPH. Looking for treatments with high efficacy and low toxicity. Toxicity and efficacy are linked. Some of Dr. Lamson's "must-have" criteria when developing a new option to assist men. The thought process that ultimately led to the creation of the UroLift system idea. Prostate tissue can be compressed. What the delivery system on Dr. Lamson's first-generation device was like. How things changed over the multiple generations of devices. There was a financial risk with the development of the system, and there were also some external difficulties. Dr. Lamson highlights some of the results of the study published in 2013. Go to the Prostate Health Academy to get a closer look at the evolution of the UroLift system over time. Links and resources: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd Get your free What To Expect Guide (or find the link here, on our podcast website) Join our Facebook group Follow Dr. Pohlman on Twitter and Instagram Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content. Ted Lamson UroLift

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related